BDNF and early-onset autosomal dominant Alzheimer disease: In addition, since SSRI antidepressants are known to elevate BDNF levels, research and clinical trials are being carried out to investigate the effect of these in Alzheimer’s disease; one such antidepressant, Citalopram, is currently undergoing Phase II clinical trials.